Stockscreener 앱 받기
67.33
8.05%
5.015
시간 외 거래:
68.00
0.675
+1.00%
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
(ANAB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Analysts Are Bullish on Top Healthcare Stocks: MindWalk Holdings (HYFT), AnaptysBio (ANAB) - The Globe and Mail
UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76 - Moomoo
AnaptysBio, Inc. Financial Disclosures & Filings - TradingView
Form 144 ANAPTYSBIO For: 30 June By Investing.com - Investing.com Nigeria
[144] ANAPTYSBIO, INC SEC Filing - Stock Titan
AnaptysBio Is Maintained at Buy by UBS - Moomoo
Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus? - simplywall.st
Price to book forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView
Enterprise value to EBITDA forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView
Form 144 ANAPTYSBIO For: 29 June By Investing.com - Investing.com Nigeria
Form DEF 14A ANAPTYSBIO For: 29 June By Investing.com - Investing.com Nigeria
Enterprise value to revenue forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView
ANAPTYSBIO, INC ($ANAB) CEO 2025 Pay Revealed - Quiver Quantitative
Affiliate plans to sell 9,476 ANAB shares (NASDAQ: ANAB) - Stock Titan
AnaptysBio (NASDAQ: ANAB) proxy details director votes and equity plan limits - Stock Titan
Price to earnings forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView
Price to sales forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView
AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell 3000E Index - marketscreener.com
AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell Microcap Index - marketscreener.com
AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
ANAB News | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill
Form 144 ANAPTYSBIO For: 26 June By Investing.com - Investing.com Nigeria
ANAB (NASDAQ) insider sells 10,000 shares; Mulroy made multiple May–June sales - Stock Titan
AnaptysBio (ANAB) Draws Valuation Attention, Is The Market Already Pricing In Future Growth? - Sahm
AnaptysBio, Inc. Actuals & Estimates (NASDAQ:ANAB) - TradingView
ANAB Forecast — Price Target — Prediction for 2027 - TradingView
AnaptysBio Inc. (ANAB) Surges 4.3% as Biotech Sentiment Improves — Key Levels to WatchQuality Factor - Město Břeclav
First Tracks Biotherapeutics (NASDAQ: TRAX) subleases 45,057 sq ft in San Diego - Stock Titan
AnaptysBio (NASDAQ: ANAB) subleases San Diego facility to First Tracks under master lease - Stock Titan
AnaptysBio Inc (ANAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
AnaptysBio Ord Shs (ANABV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Eversept Partners LP Takes $5.86 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat
AnaptysBio Inc (ANAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AnaptysBio Inc (ANAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AnaptysBio Inc (ANAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AnaptysBio, Inc. $ANAB Shares Purchased by 683 Capital Management LLC - MarketBeat
AnaptysBio Inc (ANAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AnaptysBio Inc (ANAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AnaptysBio Inc (ANAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AnaptysBio Inc (ANAB) Institutional Confidence - TradingKey
AnaptysBio Inc (ANAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
850-share sale notice by insider at ANAB (NASDAQ: ANAB) via Form 144 - Stock Titan
AnaptysBio (ANAB) director acquires 6,030 shares via RSU vesting - Stock Titan
Director at AnaptysBio (NASDAQ: ANAB) receives 6,030 shares via RSUs - Stock Titan
Director John Orwin of ANAPTYSBIO (NASDAQ: ANAB) settles 6,030 RSUs into common stock - Stock Titan
Granahan Investment Management LLC Reduces Holdings in AnaptysBio, Inc. $ANAB - MarketBeat
Dennis Mulroy sells multiple ANAB shares (NASDAQ: ANAB) across May–June 2026 - Stock Titan
Sofinnova Investments Inc. Has $13.95 Million Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat
Daily Brief United States: SpaceX, Crude Oil, DPC Holdings, CRB Commodity Index, Vistra , AnaptysBio Inc, Kardigan, Aes Corp, GE Vernova , Biomarin Pharmaceutical and more - Smartkarma
ANAB (NASDAQ: ANAB) affiliate files Form 144 to sell 20,000 shares - Stock Titan
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ANAB (NASDAQ: ANAB) affiliate files Form 144 listing multiple share dispositions - Stock Titan
Q2 Earnings Forecast for AnaptysBio Issued By HC Wainwright - MarketBeat
AnaptysBio, Inc. Stock 12‑Month Price Target Raised to $81.5, Implies 50% Upside - TradingView
Morgan Stanley (ANAB) plans 35,000-share sale; multiple insider dispositions listed - Stock Titan
1.17%
2.48%
자본화:
|
볼륨(24시간):